Major General (Ret.) Barbara R. Holcomb Joins Board at Humanetics
Retrieved on:
Tuesday, December 12, 2023
Biotechnology, Health, General Health, Pharmaceutical, Oncology, Health Technology, Veterans, Military, Other Defense, Defense, Contracts, Storm, Attention, American Public University System, MSN, Research, Humanetics, Radiation, RN, Certification, Kosovo Force, RET, Patient, BIO, BSN, COVID-19, University, DOD, Operation New Dawn, Knowledge, Army nursing, Nursing, Management
Humanetics Corporation (Humanetics), a clinical-stage specialty pharmaceutical company pioneering radiation countermeasures, adjunctive oncology therapies, and pulmonary protective therapies, has announced the addition of Major General (Ret.)
Key Points:
- Humanetics Corporation (Humanetics), a clinical-stage specialty pharmaceutical company pioneering radiation countermeasures, adjunctive oncology therapies, and pulmonary protective therapies, has announced the addition of Major General (Ret.)
- Barbara R. Holcomb, RN, BSN, MSN to its board of directors.
- “General Holcomb brings a wealth of knowledge and relevant experience that strengthens our Board,” said Ronald J. Zenk, Chief Executive Officer at Humanetics.
- Humanetics is currently working under a contract with DOD to position BIO 300 for Emergency Use.